LexisNexis® Legal Newsroom
ACA and Healthcare Reform
Antitrust and Unfair Competition
Banking and Finance
Constitutional Law and Civil Rights
Consumer Protection & Privacy
Contracts and Commercial Law
Criminal Law and Procedure
Estate and Elder Law
Financial Fraud Law
Fracking and Alternative Energy
Labor and Employment Law
Media and Entertainment
Mergers and Acquisitions
Real Estate Law
Top Emerging Trends
NEWS & INSIGHT
Blogs and Newsletters
Business of Law Blog
Corporate Law Advisory
Legal Content Insider
News & Trending Topics
Legal Insights & Trends
Lexis Practice Advisor Journal
Business Insight Solutions – Partner Portal
Corporate InfoPro (Corporate Information Professionals)
InfoPro (Legal Information Professionals)
Litigators Verdict & Settlement Exchange
VISIT LEXISNEXIS LEGAL & PROFESSIONAL
Please enter a Keyword
This should not be used for legal research but instead can be used to find solutions that will help you do legal research.
Browse By Tags
Barbara Davids v. Novartis Pharmaceuticals Corporation
e Second Circuit U.S. Court of Appeals
et al. v. Novartis Pharmaceutical Corporation
Judicial Panel on Multidistrict Litigation
Karlene Hogan v. Novartis Pharmaceuticals
Merck & Co.
Novartis Pharmaceuticals Corp.
over 6 years ago
Jury Awards $1.3 Million In Zometa Jaw Injury Trial After Botching 1st Verdict Form
ORLANDO, Fla. — (Mealey’s) A Florida federal jury on Sept. 20 found that Novartis Pharmaceuticals Corp. failed to warn a cancer patient about the risk of osteonecrosis of the jaw (ONJ) and awarded her $1.3 million in medical expenses and non...
over 7 years ago
Jury Awards Plaintiff $10.4 Million For Injuries, Punitive Damages Linked To Novartis' Zometa
CENTRAL ISLIP, N.Y. - (Mealey's) A New York federal jury on Nov. 2 found Novartis Pharmaceuticals Corp. liable for a woman's osteonecrosis of the jaw (ONJ) and awarded her $10.45 million, according to the parties ( Barbara Davids v. Novartis Pharmaceuticals...
over 9 years ago
2nd Fosamax Bellwether Plaintiff Failed To Prove Causation, 2nd Circuit Affirms
NEW YORK - (Mealey's) The second bellwether plaintiff in the Fosamax multidistrict litigation failed to produce evidence that the osteoporosis drug caused her osteonecrosis of the jaw (ONJ), a panel of the Second Circuit U.S. Court of Appeals ruled...
over 8 years ago
Novartis Wins Defense Verdict In Zometa Jaw Injury Trial
BROOKLYN, N.Y. (Mealey's) A New York federal jury in the first federal Zometa trial found May 25 that the plaintiff did not prove by a preponderance of evidence that the Novartis Pharmaceuticals Corp. drug caused a decedent's osteonecrosis of...
over 5 years ago
Merck To Settle Suits Alleging Jaw Damage From Osteoporosis Drug
WHITEHOUSE STATION, N.J. — (Mealey's) Merck & Co. Inc. has agreed to pay $27.7 million to resolve product liability suits alleging that its osteoporosis drug Fosamax caused osteonecrosis of the jaw (ONJ), or bone death, according to a press...
Latin America and the Caribbean
Europe, Africa and Middle East
International Sales(Includes Middle East)
Rule of Law
Top Product Pages
Sign-In Index Page
Legal & Professional Solutions
Terms & Conditions